logo
Urgent recall for 19,000 Dr Pepper Zero Sugar cans over 'serious' health risk

Urgent recall for 19,000 Dr Pepper Zero Sugar cans over 'serious' health risk

Metroa day ago

More than 19,000 cans of Dr Pepper Zero Sugar have been recalled in the US over fears of 'serious adverse health consequences' to some consumers.
The 19,203 cans have been recalled by Pepsi Beverages Company, which is licensed to manufacture Keurig Dr Pepper products, due to mislabeling.
'Product labeled to be Zero Sugar contains full sugar product,' states a notice published by the nation's agency tasked with ensuring food, drugs and products are safe for the public.
People with diabetes and others who are sensitive to sugar could become seriously ill.
The affected soda was packaged in aluminum cans and sold in packs of 12 and 24. They have the best by date of February 16, 2026, and the product code XXXXRS05165. More Trending
They were shipped to three US states: Florida, Georgia and South Carolina.
The company initiated a voluntary recall on May 23 of this year, but the US Food and Drug Administration (FDA) reclassified it to a Class II level on Thursday.
A Class II recall is 'a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote', according to the FDA.
The reclassification comes days after the Coca-Cola Company recalled 'limited quantities' of its Topo Chico mineral water sent to five US states over possible bacterial contamination. The affected Topo Chico bottles were sent to 40 retail locations in Arizona, Louisiana, Nevada, New Mexico and Texas.
Get in touch with our news team by emailing us at webnews@metro.co.uk.
For more stories like this, check our news page.
MORE: Urgent recall of American sweets 'unsafe to eat and not compliant with UK law'
MORE: Chemical spill at explosives plant sends massive orange plume into air in Ohio
MORE: Leeds General Infirmary cordoned off after suspicious package is found

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

US FDA puts on hold Rein Therapeutics' lung disease drug trial
US FDA puts on hold Rein Therapeutics' lung disease drug trial

Reuters

time5 hours ago

  • Reuters

US FDA puts on hold Rein Therapeutics' lung disease drug trial

June 12 (Reuters) - Rein Therapeutics (RNTX.O), opens new tab has paused patient enrollment and dosing in a mid-stage trial of its lung disease drug in the U.S. after the Food and Drug Administration placed a clinical hold, the drug developer said on Thursday. Shares of the company fell nearly 10% after the bell. The company was testing a drug named LTI-03 to treat patients with idiopathic pulmonary fibrosis (IPF). The disease causes scarring of the lungs that makes it harder for them to work properly. Rein said in a filing that it is actively working with the FDA to remove the clinical hold. The FDA and Rein did not immediately respond to Reuters' requests for comment on why the hold was placed. The drug was well-tolerated and safe in an early-stage study in patients with IPF, the company said in the filing. No drug-related serious adverse events have been reported in any studies treating patients with LTI-03, it added. Rein continues to study the drug and enroll patients in Australia and Europe.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store